Literature DB >> 27427218

Burden of lymphatic filariasis morbidity in an area of low endemicity in Brazil.

Maria José Netto1, Cristine Bonfim2, Eduardo Brandão1, Ana Maria Aguiar-Santos1, Zulma Medeiros3.   

Abstract

The Global Programme to Eliminate Lymphatic Filariasis has two main components: interrupting transmission of lymphatic filariasis (LF) and managing morbidity and preventing disability. However, interventions to prevent and manage LF-related disabilities in endemic communities have been of limited extent. The aim of this study was to describe the prevalence of morbidity and its correlation with filarial infection, thereby filling a gap that existed regarding the data on morbidity in Brazil. Presence of Wuchereria bancrofti microfilaria was investigated using the thick smear technique. Information on parasitosis-related clinical manifestations was obtained using a questionnaire applied by community health agents with previous training and capacitation to know about and identify the disease. To analyze correlations, Pearson's correlation coefficient was used with the corresponding statistical significance test. 23,673 individuals were investigated: 323 presented microfilaremia (1.36%) and 741 (3.13%) had clinical complaints that were attributable to LF. Acute dermatolymphangioadenitis (ADLA) was the most prevalent condition (2.2%). Lymphedema, ADLA and chyluria were more commonly reported among female patients. There were positive associations between all the clinical complaints reported and filarial infection. Hydrocele presented the most strongly positive association (r=0.699; p<0.001). The present study showed that there is an association between clinical condition reported and the rate of infection among people living in an area of low endemicity for LF. It contributes data that might provide support for healthcare systems and thus optimize disease management, through incorporating surveillance measures directed towards preventing disability and reducing the psychosocial and economic impact of the disease on poor populations living in areas endemic for LF.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Control; Elimination; Hydrocele; Lymphatic filariasis; Lymphedema; Morbidity; Neglected tropical diseases; Wuchereria bancrofti

Mesh:

Year:  2016        PMID: 27427218     DOI: 10.1016/j.actatropica.2016.07.006

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  4 in total

1.  Evaluation of lymphatic filariasis in endemic area of Brazil where mass drug administration is not required.

Authors:  Ellyda Silva; Amanda Xavier; Elis Silva; Walter Barbosa Júnior; Abraham Rocha; Vania Freitas; Paula Oliveira; Ana Maria Aguiar-Santos; Cristine Bonfim; Zulma Medeiros
Journal:  Pathog Glob Health       Date:  2019-05-29       Impact factor: 3.735

2.  Microcephaly epidemic related to the Zika virus and living conditions in Recife, Northeast Brazil.

Authors:  Wayner Vieira de Souza; Maria de Fátima Pessoa Militão de Albuquerque; Enrique Vazquez; Luciana Caroline Albuquerque Bezerra; Antonio da Cruz Gouveia Mendes; Tereza Maciel Lyra; Thalia Velho Barreto de Araujo; André Luiz Sá de Oliveira; Maria Cynthia Braga; Ricardo Arraes de Alencar Ximenes; Demócrito de Barros Miranda-Filho; Amanda Priscila de Santana Cabral Silva; Laura Rodrigues; Celina Maria Turchi Martelli
Journal:  BMC Public Health       Date:  2018-01-12       Impact factor: 3.295

3.  Assessment of transmission in areas of uncertain endemicity for lymphatic filariasis in Brazil.

Authors:  Amanda Xavier; Heloize Oliveira; Ana Aguiar-Santos; Walter Barbosa Júnior; Ellyda da Silva; Cynthia Braga; Cristine Bonfim; Zulma Medeiros
Journal:  PLoS Negl Trop Dis       Date:  2019-11-25

Review 4.  Lymphatic Filariasis: A Systematic Review on Morbidity and Its Repercussions in Countries in the Americas.

Authors:  Zulma M Medeiros; Amanda V B Vieira; Amanda T Xavier; Gilberto S N Bezerra; Maria de Fátima C Lopes; Cristine V Bonfim; Ana M Aguiar-Santos
Journal:  Int J Environ Res Public Health       Date:  2021-12-28       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.